Zhiwei Chen
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Virology 91
- HIV Research and Treatment 85
-
- SARS-CoV-2 and COVID-19 Research 37
- HIV/AIDS drug development and treatment 31
- COVID-19 Clinical Research Studies 18
- HIV/AIDS Research and Interventions 17
- Co-authors
- David D. HoEnrico DiLi LiuF. Scott MathewsPreston A. MarxLinqi ZhangKwok‐Yung YuenNicola Pozzi
- Journals
- Journal of Virology (21 papers)Journal of Biological Chemistry (17 papers)PLoS ONE (11 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (9 papers)Biochemistry (8 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Zhiwei Chen
376 papers receiving 11.4k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Virology 2.2k
- Infectious Diseases 4.1k
- Immunology 2.2k
- General Dentistry 169
- Hematology 746
Countries citing papers authored by Zhiwei Chen
This map shows the geographic impact of Zhiwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwei Chen more than expected).
Fields of papers citing papers by Zhiwei Chen
This network shows the impact of papers produced by Zhiwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwei Chen. The network helps show where Zhiwei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhiwei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 30 | |
| 11 | 2022 | 30 | |
| 12 | 2022 | 12 | |
| 13 | Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 Hit paper breakdown → | 2022 | 433 |
| 14 | 2021 | 6 | |
| 15 | 2021 | 24 | |
| 16 | 2020 | 346 | |
| 17 | ODC1 promotes proliferation and mobility via the AKT/GSK3β/β-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma | 2019 | 0 |
| 18 | 2017 | 16 | |
| 19 | 2014 | 29 | |
| 20 | 2008 | 88 |
About Zhiwei Chen
Zhiwei Chen is a scholar working on Virology, Infectious Diseases, Immunology, Hematology and Epidemiology, having authored 396 papers that have together received 11.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (85 papers), Immune Cell Function and Interaction (47 papers), SARS-CoV-2 and COVID-19 Research (37 papers), HIV/AIDS drug development and treatment (31 papers), Blood Coagulation and Thrombosis Mechanisms (27 papers), Immunotherapy and Immune Responses (26 papers), COVID-19 Clinical Research Studies (18 papers) and HIV/AIDS Research and Interventions (17 papers). The work is most often cited by research in Virology (2.2k citations), Infectious Diseases (4.1k citations), Immunology (2.2k citations), General Dentistry (169 citations) and Hematology (746 citations). Zhiwei Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include David D. Ho, Enrico Di, Li Liu, F. Scott Mathews, Preston A. Marx, Linqi Zhang, Kwok‐Yung Yuen, Nicola Pozzi, Agegnehu Gettie and Chuan Qin. Their work appears in journals such as Journal of Virology, Journal of Biological Chemistry, PLoS ONE, JAIDS Journal of Acquired Immune Deficiency Syndromes and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.